BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7280442)

  • 1. Clinical studies of pneumococcal vaccines in infants. II. Efficacy and effect on nasopharyngeal carriage.
    Wright PF; Sell SH; Vaughn WK; Andrews C; McConnell KB; Schiffman G
    Rev Infect Dis; 1981; 3 Suppl():S108-12. PubMed ID: 7280442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of pneumococcal polysaccharide vaccine in preventing acute otitis media in infants in Huntsville, Alabama.
    Sloyer JL; Ploussard JH; Howie VM
    Rev Infect Dis; 1981; 3 Suppl():S119-23. PubMed ID: 7280444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the pneumococcal vaccine in prevention of clinically acute atttacks of recurrent otitis media.
    Mäkelä PH; Leinonen M; Pukander J; Karma P
    Rev Infect Dis; 1981; 3 Suppl():S124-32. PubMed ID: 6974386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of pneumococcal vaccine for prevention of recurrent acute otitis media in infants in Boston. The Greater Boston Collaborative Otitis Media Study Group.
    Teele DW; Klein JO; Bratton L; Fisch GR; Mathieu OR; Porter PJ; Starobin SG; Tarlin LD; Younes RP
    Rev Infect Dis; 1981; 3 Suppl():S113-8. PubMed ID: 7280443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of polyvalent pneumococcal polysaccharide vaccine on nasopharyngeal and nasal carriage of Streptococcus pneumoniae.
    Herva E; Luotonen J; Timonen M; Sibakov M; Karma P; Mäkelä PH
    Scand J Infect Dis; 1980; 12(2):97-100. PubMed ID: 6990475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.
    Cohen R; Levy C; de La Rocque F; Gelbert N; Wollner A; Fritzell B; Bonnet E; Tetelboum R; Varon E
    Pediatr Infect Dis J; 2006 Nov; 25(11):1001-7. PubMed ID: 17072121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Otitis Media with Spontaneous Perforation of the Tympanic Membrane in Young Children and Association with Bacterial Nasopharyngeal Carriage, Recurrences and Pneumococcal Vaccination in Catalonia, Spain - The Prospective HERMES Study.
    Cilveti R; Olmo M; Pérez-Jove J; Picazo JJ; Arimany JL; Mora E; Pérez-Porcuna TM; Aguilar I; Alonso A; Molina F; Del Amo M; Mendez C;
    PLoS One; 2017; 12(2):e0170316. PubMed ID: 28146590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine.
    Dagan R; Melamed R; Muallem M; Piglansky L; Greenberg D; Abramson O; Mendelman PM; Bohidar N; Yagupsky P
    J Infect Dis; 1996 Dec; 174(6):1271-8. PubMed ID: 8940218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media.
    Veenhoven RH; Bogaert D; Schilder AG; Rijkers GT; Uiterwaal CS; Kiezebrink HH; van Kempen MJ; Dhooge IJ; Bruin J; Ijzerman EP; de Groot R; Kuis W; Hermans PW; Sanders EA
    Clin Infect Dis; 2004 Oct; 39(7):911-9. PubMed ID: 15472839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute otitis media in the era of effective pneumococcal conjugate vaccine: will new pathogens emerge?
    Pelton SI
    Vaccine; 2000 Dec; 19 Suppl 1():S96-9. PubMed ID: 11163471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 13-year survey of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 and PCV13 implementation.
    Cohen R; Varon E; Doit C; Schlemmer C; Romain O; Thollot F; Béchet S; Bonacorsi S; Levy C
    Vaccine; 2015 Sep; 33(39):5118-26. PubMed ID: 26271823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media.
    Cohen R; Levy C; Bingen E; Koskas M; Nave I; Varon E
    Pediatr Infect Dis J; 2012 Mar; 31(3):297-301. PubMed ID: 22330166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal resistance and serotype 19A in Pittsburgh-area children with acute otitis media before and after introduction of 7-valent pneumococcal polysaccharide vaccine.
    Hoberman A; Paradise JL; Shaikh N; Greenberg DP; Kearney DH; Colborn DK; Rockette HE; Kurs-Lasky M; McEllistrem MC; Zoffel LM; Balentine TL; Barbadora KA; Wald ER
    Clin Pediatr (Phila); 2011 Feb; 50(2):114-20. PubMed ID: 21098526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical studies of pneumococcal vaccines in infants. I. Reactogenicity and immunogenicity of two polyvalent polysaccharide vaccines.
    Sell SH; Wright PF; Vaughn WK; Thompson J; Schiffman G
    Rev Infect Dis; 1981; 3 Suppl():S97-107. PubMed ID: 7280450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasopharyngeal s. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme.
    Wouters I; Van Heirstraeten L; Desmet S; Blaizot S; Verhaegen J; Goossens H; Van Damme P; Malhotra-Kumar S; Theeten H;
    Vaccine; 2018 Jan; 36(1):15-22. PubMed ID: 29180027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
    Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M
    Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
    van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
    Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines.
    Hilleman MR; Carlson AJ; McLean AA; Vella PP; Weibel RE; Woodhour AF
    Rev Infect Dis; 1981; 3 Suppl():S31-42. PubMed ID: 7025159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers.
    Dagan R; Givon-Lavi N; Zamir O; Sikuler-Cohen M; Guy L; Janco J; Yagupsky P; Fraser D
    J Infect Dis; 2002 Apr; 185(7):927-36. PubMed ID: 11920317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.